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Introduction
In mammals, the heart is the first organ to form during development. At midgastrulation in the mouse, mesodermal cells that will form the heart are set aside after ingression through the primitive streak of the E7.5 gastrula. They then migrate into position at day E7.75-8.0 and begin beating at day E8.5.
1 At day E7.5, the mesodermal cells that will become heart first express Csx/Nkx2-5. This gene is a putative transcription factor that is specific for the heart when cardiac mesoderm is produced, throughout cardiogenesis, and in the adult heart. 2 3 By day E7.5-8.0, the early myocardial cells express cardiac actin and MLC-2v. 4 5 Csx/Nkx2-5 and then MLC-2v are expressed in cultured mouse embryonic stem cells just before they differentiate into the beating heart. 3 4 The differentiation of the mesoderm into heart first requires the presence of Spemann's organizer and then deep anterior/pharyngeal endoderm in amphibians and chicks. 1 6 This inductive influence of the endoderm may act at a distance, perhaps by diffusible growth factors. 1 The two edges of the migrating mesoderm meet at the ventral midline and fuse to form (1) the early endocardium, (2) the early myocardium, and (3) the early pericardium. The endocardial tube is invested with myocardium by day E8.0-8.5 in the mouse. As the two primordia fuse at the ve ntral midline to form a tube, the rate of mitosis reaches its highest point. 1 Within half a day after the mesoderm fuses, the heart has differentiated, the initial specification of atria, ventricles, and outflow tract has occurred, and the heart is beating. Little is known of the molecular mechanisms that mediate the migration, growth, determination, and finally the differentiation that lead to the beating heart. The data on heart muscle-specific structural genes and transcription factors isolated in the chick and mouse correlate well with the temporal events in heart development described above.
2 3 4 7 8 9 10 11 12 13 However, there have been few studies on the expression and function of growth factors in the early development of the heart. The expression and function of TGF-ß3 has been studied in the later development of the heart during valve formation. 14 There have been studies of the early prefunctional stage of development of the heart, particularly of the expression of FGF-8 15 and of TGF-ß. 16 In mammals, the expression of HGF ligand has not been studied through gastrulation.
HGF is a heterodimeric protein implicated in the development and regeneration of the liver and in other mesenchymal-epithelial interactions during development after gastrulation. 17 HGF requires a proteolytic processing step that cleaves the propolypeptide into and ß subunits of 70 and 35 kD. The and ß subunits of HGF contain four kringle domains and a protease-like domain, respectively. 26 HGF is also detected in the dermis and kidney, where it may have a role in development, and in the fetal liver. 25 26 27 The expression of the HGF gene has not been studied in the period before day E10 in the mouse when heart development has initiated.
The receptor for HGF has been identified as the c-met proto-oncogene, a heterodimeric transmembrane tyrosine kinase that is generally distributed apposite the HGF mRNA in postgastrulation embryo and in adult mammals. 26 28 It requires ligand-induced dimerization of the cytosolic tyrosine kinase domains of two HGF receptors to transmit a signal into the cell. 29 The HGF receptor/c-met activates a signal pathway through a complex that may include nonenzymatic SH-2 domain-containing protein and a protein tyrosine phosphatase. 30 31 Ron and Sea are genes with homology to c-met/HGF receptor in the tyrosine kinase and extracellular domain. 32 33 Ron is the receptor for MSP but does not bind HGF. 23 During later embryonic developmental in the mouse, c-met/HGF receptor is expressed in epithelia adjacent to HGF ligand expression in the mesenchyme. 26 In mammals, the expression of HGF receptor has not been studied in the period spanning gastrulation and the initiation of heart development.
Some functional studies on the role of HGF in development have been performed previously. HGF is an apparent inducer of neuroectoderm during gastrulation in the chick and frog. HGF induces neural tissue in frog ectoderm, and implanted HGF-carrying beads perturb the primitive streak in the chick. 34 The implanted beads cause the mesoderm induced at gastrulation to move toward the beads, creating a second mesodermal axis and, later, a second neuroectodermal axis. This neuroectoderm may also be directly induced by HGF. 35 The neuroectodermal induction mediated by HGF would occur at a time and in a position in which gastrulating mesoderm would be induced to form the heart, but this has not been studied directly in Xenopus or chick. In mouse, ablation of HGF or HGF receptor by homologous recombination results in embryonic lethality between days E12 and E16.5. Defects in the development of the placenta and liver are thought to cause the lethality, but some defects in heart have been noted previously. 36 37 38 To test for a role in heart development, we assayed for the expression of the HGF ligand and receptor mRNA in the early development of the heart in the mouse embryo. We found that HGF and its receptor are coexpressed in the ectoderm and mesoderm of the midgastrulation-stage mouse but that the coexpression restricts to mesoderm that will form cardiac myocytes toward the end of gastrulation. The coexpression of HGF and its receptor persists through the first functioning of the heart and then stops. These data suggest that the coexpression of HGF and its receptor may have a role in the early development of the beating heart. cRNA was prepared from plasmid DNA by linearization and runoff transcription with T7 polymerase and SP6 polymerase in sense and antisense directions for each plasmid. 43 Runoff transcripts were labeled using digoxygenin-UTP and were treated with RNase-free DNase to remove the template (Genius RNA labeling kit, Boehringer-Mannheim). Unincorporated nucleotides were removed by purification of synthetic RNA by anion column chromatography (QIAquick nucleotide removal kit, QIAGEN). The sensitivity of the labeling was assayed by dilutions of dot blots (Genius RNA labeling kit, Boehringer-Mannheim). An effort was made to maximize the sensitivity of the detection of the HGF ligand and receptor genes. In doing this, the ability to compare relative amounts of the two genes was sacrificed. In short, the color development was allowed to proceed until maximal reaction product developed without appreciable background in the antisense or sense reactions. Time courses for intensity of development were not done. For in situ hybridization on sections, the time of development was 5 hours for HGF ligand and 2.5 hours for HGF receptor. For whole mounts, the development was terminated at 2.5 hours for HGF ligand and receptor. The sensitivities for the digoxygenin-labeled RNA were as follows: for HGF ligand, antisense, 0.03 pg, and sense, 0.08 pg; for HGF receptor, antisense, 0.02 pg, and sense, 0.02 pg. 35 S riboprobes were synthesized as per Wilcox, 44 with the following modifications: After synthesis of the probe, 1 µL of RQ1 DNase (Promega) was added to the transcription reaction and incubated for 15 minutes at 37°C. The unincorporated nucleotides were removed using QIAquick nucleotide removal kit. In situ hybridization and autoradiography were performed as described in Wilcox, 44 except proteinase K treatment was with 20 µg/mL for 5 minutes at room temperature.
In situ hybridization was performed by a modified protocol of Harkey et al, 43 with the following modifications. Sections of paraffin were first dewaxed in xylene, rinsed in 100% ethanol, and air-dried. Sections were rehydrated through an ethanol series, washed in PBT (PBS containing 0.1% Tween 20), and treated with proteinase K (20 mg/mL in PBT). The proteinase K was neutralized with 0.2% glycine in PBS, washed with PBT, refixed with 4% paraformaldehyde in PBS, and washed in PBT. The slides were transferred to a humidified box and prehybridized (50% formamide, 10% polyethylene glycol, 0.6 mol/L NaCl, 5 mmol/L EDTA, 20 mmol/L Tris [pH 7.5], 500 µg/mL yeast tRNA, 0.1% Tween 20, and 10x Denhardt's [1x Denha rdt's contains 2% Ficoll, 2% polyvinylpyrrolidone, and 2% BSA]) at 50°C for 1 hour. The prehybridization solution was removed; 10 µL of hybridization solution containing 100 ng digoxygeninlabeled RNA probe was added; and the slide was covered with a coverglass, sealed with rubber cement, and hybridized at 50°C in a humidified box overnight. All labeled probes had previously been tested by dot blot hybridization and were in the range of 20-to 100-fmol sensitivity. After hybridization, the coverglass was removed, and the slides were washed at 50°C in 50% PBT/50% prehybridization solution, in PBT at 50°C, and in 1x SSC at 60°C. Slides were washed in PBT, incubated with PBT containing 2% normal sheep serum to block nonspecific binding, and incubated with a 1:2000 dilution of anti-digoxygenin/alkaline phosphatase conjugate in PBT/1% normal sheep serum. Slides were washed in PBT and then for 5 minutes in alkaline phosphatase buffer (100 mmol/L Tris [pH 9.5], 100 mmol/L NaCl, 50 mmol/L MgCl 2 , 0.1% Tween 20, and 1 mmol/L levamisole). The color reaction was carried out as previously described 43 until a maximum amount of product was visible but before product was generated in sense controls. The reaction was stopped with PBT; the slides were stained with Hoechst 33258 (10 µg/mL in water), destained in water, dehydrated through an alcohol series, and mounted in media (Tris-EDTA with NaN 3 ); the coverslips were sealed with rubber cement. Who le-mount in situ hybridization was performed by the method of Rosen and Beddington.
Results
We first showed that our digoxygenin-labeled cRNA, developed with an alkaline phosphatase reaction, detected only the HGF mRNA in the liver of a day E13 embryo. At this stage, in situ hybridization with a cDNA encoding the entire coding sequence and the entire 3'-untranslated region of the HGF gene detected HGF transcripts in a small subpopulation of Ito cells in the liver but not in the parenchymal cells (data not shown). 22 46 HGF ligand mRNA was also detected in the glomerular mesenchyme but not in the collecting tubules of the embryonic and adult kidney (data not shown). 17 21 This indicates that our probe matches the reported distribution of HGF mRNA in Ito cells and kidney cells but does not detect MSP/HGF-like protein mRNA in parenchymal cells of the liver, where HGFlike protein is expressed. Finally, HGF receptor mRNA was detected in labyrinthine placenta, and HGF ligand mRNA was detected in allantois at midgastrulation, as reported recently by Uehara et al 37 (authors' unpublished data, 1996). The cDNA for the c-met/HGF receptor was wholly derived from the segment of the 3'-untranslated region of the gene and has little homology with the related receptors, Ron and Sea, in this region. 23 24 28 32 33 47 We have detected HGF mRNA in heart primordium in sections of the late gastrulation stage at day E8.5. In serial sections, HGF ligand mRNA was detected in precursors to a subpopulation of cardiac myocytes that will later populate the ventricles and atria but not the outflow-tract mesoderm, endocardium, or endoderm (Fig 1 ) . HGF receptor mRNA was detected in the same early heart myocardial cells as the HGF ligand but not in nearby endocardium or endoderm (Fig 2 ) . Sense controls for HGF ligand and receptor were negative for the sections of early heart (Figs 1 and 2 and data not shown). Figure 1 . HGF mRNA is expressed in early myocardial cells enveloping the endocardium (EC) in the day E8.5 mouse embryo. Day E8.5 mouse embryos were sectioned transversely and fixed, and HGF mRNA was detected by in situ hybridization using antisense HGF ligand cRNA in a modified digoxygenin protocol. In panels A and B, NF indicates neural fold; MYO, myocardium. Note that the fused ventricular MYO envelops the EC, which is unstained. Panel C shows the partial atrial myocardium (stained) and the connected structure above, the unstained outflow tract. In panels B and D, the same sections as in panels A and C, respectively, are shown after staining with Hoechst to detect nuclei. Original magnification x250. Sense controls were negative (not shown).
View larger version (83K): [in this window]
[in a new window] Figure 2 . HGF receptor mRNA is expressed in early myocardial cells enveloping the endocardium (EC) in the day E8.5 mouse embryo. Day E8.5 mouse embryos were sectioned transversely and fixed, and HGF receptor mRNA was detected by in situ hybridization using antisense HGF receptor cRNA in a modified digoxygenin protocol. In panels A and B, PE indicates pharyngeal endoderm; MYO, myocardium. In panels A and B, the fused ventricular MYO envelops the EC. HGF receptor mRNA is detected in the MYO but not the EC. In panels C and D, EN indicates endoderm; NF, neural fold; OT, outflow tract, and MYO, atrial MYO. Note the identity in patterns of expression in panels A and C in Figs 1 and 2 from adjacent sections at anterior-posterior levels of the heart. In panels B and D, the same sections as in panels A and C, respectively, are shown after staining with Hoechst to detect nuclei. Panel E is a similar section of the E8.5 day embryo hybridized with sense HGF receptor mRNA as a negative control, and panel F is the same section after staining with Hoechst to detect nuclei. Original magnification x250.
To time the beginning and end of expression of the HGF ligand and receptor mRNA, whole-mount in situ hybridizations were performed on 60 embryos at day E7.75-8.75. Using antisense digoxygenintagged cRNA with an enzymatic development with alkaline phosphatase for whole-mount in situ hybridization, HGF receptor mRNA was detected in the presomitic day E7.75 embryo in the precardiac mesoderm and in adjacent endoderm (Fig 3 and Table ) . HGF receptor mRNA was detected in the 5-somite heart primordium just as it was about to begin beating. 1 By the 11-somite stage, expression of HGF receptor mRNA had decreased, and after the 14-somite stage, HGF receptor mRNA was not detected (Fig 3 and Table ) . Sense controls for whole embryos were negative for HGF receptor (data not shown). HGF receptor mRNA was detected primarily in mesodermal precursors of the heart but appeared to be detected in the endoderm next to the presumptive heart (Fig 3 ) . However, no HGF receptor mRNA was detected in endoderm after postsectioning of the whole mounts or in sections of day E7.5-8.0 embryos (data not shown, Fig 5 below) . HGF ligand mRNA was not detected in the early myocardial mesoderm or in the endoderm that is adjacent to the early myocardial mesoderm (Fig  4 , embryos 1 and 2) . The heart-specific expression of HGF ligand mRNA began later than that of HGF receptor. HGF receptor mRNA was detected in early myocardial mesoderm (Fig 3 ) , but HGF mRNA was not detected in the early myocardial mesoderm in similar embryos at any headfold stage (Fig 4 and Table ; data not shown). HGF ligand mRNA was first detected in the fused cardiac mesoderm of the 2-to 3-somite embryo before looping of the heart had started and persisted through the 16-to 18-somite stage, whereas the c-met/HGF receptor was expressed in the early headfold stage through the 8-to 14-somite stage (Figs 3 and 4 and Table ) . Sense controls for whole embryos were negative for HGF ligand (data not shown). The c-met/HGF receptor and HGF ligand were always detected in the heart before the looping of the heart and turning of the embryo (Table ) . c-met/HGF receptor and HGF ligand were always detected before the first beating of the heart, which occurred between the 4-and 8-somite stage (data not shown). Relative to each other, turning, somite number, and the first heartbeat, were variable. To determine the expression of HGF ligand and receptor in more detail, the embryos were embedded and sectioned after whole-mount in situ hybridization. In these sections, HGF ligand and receptor mRNA were detected in all myocardium after fusion of the migrating heart mesoderm to form a closed tube. However, no HGF ligand or receptor mRNA was conclusively detected in endoderm or in mesoderm before fusion (data not shown). To further test for expression of HGF ligand and receptor mRNA, embryos at E7.5-8.5 were sectioned and processed using a more sensitive technique, by hybridization with runoff synthetic RNA labeled with 35 S ribonucleotides to high specific activity (10 9 cpm/µg). HGF ligand and receptor mRNA were not detected in endoderm or endocardium; however, HGF receptor mRNA was detected in unfused migrating myocardial mesoderm (Fig 5 ) . However, HGF ligand was not detected at the same stage. This embryo was staged between E7.5 and E8.5 (Reference 48 48 , plate 9e,f therein), since it lacked extensive cardiac morphology, including any fused structures (characteristic of day E7.5), yet had a foregut diverticulum with endoderm that formed some pharyngeal pouches (characteristic of day E8.0; note arrowheads in Fig 5A , 5C , 5E , and 5G ). In addition, there was an intraembryonic coelom (precursor to the pericardial cavity), a cardiogenic plate, (subjacent to this) an asymmetric unilateral sheet of endocardium, and (further subjacent to this) an asymmetric unilateral sheet of myocardium. In hematoxylin and eosin-counterstained sections, two continuous sheets of flattened nuclei with a intercalated basement membrane were seen forming a circle around the entire embryo (and the cavity in the deciduum where the embryo was found) and adjacent to the maternal deciduum (Fig 5C , data  not shown) . These two sheets were determined to be parietal endoderm and trophectoderm, by comparison with similar structures at E6.5-7.5. 48 HGF receptor was detected solely in the slip of myocardium between the cardiogenic plate/endocardium and the parietal endoderm. We speculate that the unilateral expression of HGF receptor mRNA has two possible explanations. The first explanation is that the transverse section was cut obliquely and detected fused or unfused myocardium only on one side. Since the expression was observed in five consecutive 5-µm sections and the morphology of the transverse section was near normal, 48 it is more likely that this was unfused myocardium. The second explanation is that mesoderm migration from the cardiogenic plate is asymmetric in time and occurs "sloppily" and that the fusion resolves this at a later stage. We have noted some asymmetry of migration in five embryos (see also Fig 3 , embryo 1 ) and favor the second explanation.
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[in this window] [in a new window] Figure 3 . HGF receptor mRNA is expressed in mouse heart from days E7.75 to E8.75. Whole-mount in situ hybridization was performed using digoxygenin-labeled antisense cRNA probes and developed using alkaline phosphatase. From left to right, embryos are as follows: 1, E7.75; 2, E7.9; 3, E8.0; 4, E8.25; 5, E8.25; and 6, E8.5. Arrowheads show the heart primordia or heart at each stage. In embryo 2, a second arrowhead shows expression in the two fusing myocardial primordia. Note some asymmetry of expression in embryo 1. The embryos have been placed in the following orientations: in all, anterior is on top and posterior is on bottom. Embryos 1, 2, and 3 are shown from the ventral surface, and embryos 4 and 5 show the ventral surface facing to the left. All five embryos show positive staining in the myocardial mesoderm. The scale of the embryos in the two orientations is not the same. Controlsense hybridizations showed no staining. Evaluation of whole-mount in situ hybridizations like those represented in Figs 3 and 4 . Intensity of heart staining is given on a scale of --to +++. Morphology of heart and embryo is given in terms of whether the heart is fused or looped. Embryo somite number ( 3 to 5 at day E8.0) is given, along with indication of whether or not the embryo has "turned" (which occurs at day E8.5). The somite number is approximate. Variation in the intensity of staining of the HGF ligand at somites 13 and 17 may be due to incomplete penetration of reagents during hybridization, incorrect somite counts, or biological diversity. Figure 4 . HGF ligand mRNA is expressed in mouse heart from E8.0 to E 8.75. Whole-mount in situ hybridization was performed using digoxygenin-labeled antisense cRNA probes and developed using alkaline phosphatase. From left to right, embryos are as follows: 1, E7.75; 2, E7.9; 3, E8.25; 4, E8.75; 5, E8.75; 6, E9.0; 7, E9.5; and 8, 8.75 . White arrowheads show expression in the heart primordia or heart at each stage, and black arrowheads show heart primordia or heart that lack expression. In embryo 8, white arrowheads show a heart removed from the thorax and the position from which it was taken. The embryos have been placed in the following orientations: in all, anterior is on top and posterior is on bottom; embryos 1 and 2 are shown from the ventral surface, and in embryos 3 through 8, the ventral surfaces face to the left. Embryos 1, 2, and 6 lack staining and embryos 3 through 5 are stained in myocardial mesoderm. The embryos in the two orientations are not to the same scale. Control sense hybridizations showed no staining.
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[in this window] [in a new window] . In panel C, the flattened nuclei above the numbers 1 though 6 are parietal EN cells, and the flattened nucleus at the base of 3 is trophectoderm. Note that in panels A, C, and D the large nuclei that are seen in the DEC are adjacent to MYO on the right side but that on the left side, they are directly adjacent to the CP. Panels E, F, and G are similar to sections in panels A, B, and C, respectively. These are transverse sections of an E7.5-8.0 embryo with pharyngeal pouches (note arrowheads in panels A, C, E, and G).
the earliest steps in determination of the heart. HGF ligand and receptor mRNA are first expressed concomitantly with cardiac actin (which is first detected near the headfold at day E7.5) and MLC-2v 4 5 and may be part of a set of genes regulated by master regulatory genes for heart development.
Since HGF and its receptor are coexpressed in the developing heart, HGF signaling may also be involved with autoregulation and maintenance of the phenotype of early myocardial cells once they have been determined. HGF ligand is generally expressed in mesoderm-derived cells apposite the ectoderm-derived cells that express HGF receptor/c-met. 25 26 27 The HGF ligand-receptor pair are not commonly coexpressed. Interestingly, HGF ligand and receptor are coexpressed in somites before the myotomes disperse and form skeletal muscle of the trunk. 26 The expression of the HGF receptor in somites is absolutely required for migration of somitic muscle precursors into the limb bud, where the HGF ligand is expressed. 38 It is possible that HGF ligand and receptor mediate autocrine and/or paracrine mechanisms of morphogenetic events common to the development of cardiac and skeletal muscle. Since the HGF receptor is detected in migratory myocardial mesoderm before fusion in the day E7.5-8.0 embryo, it is suggested that HGF plays a role in this migration. The location of a ligand that binds the HGF receptor in migrating myocardial mesoderm is not known. It may be that HGF ligand is expressed in the same myocardial mesoderm but is below the threshold of detection. An alternate possibility is that another, as yet unidentified, ligand for the HGF receptor is expressed.
In some amphibians and in the chick, pharyngeal endoderm induces mesoderm set aside during midgastrulation to form the heart (References 1 and 6 1 6 and M. Mercola, personal communication, 1995). Since HGF ligand is not detected in pharyngeal endoderm, it is unlikely that HGF mediates the induction of heart mesoderm by endoderm in the mouse. It is also possible that HGF, below the levels detected by our in situ hybridization, may mediate such an induction.
A number of observations of the expression and function of HGF at midgastrulation suggest a role for HGF in the setting aside of mesoderm fated to become heart. At day E7.0-7.5, the midgastrulation embryo expresses HGF ligand and receptor in the mesoderm and ectoderm (authors' unpublished data, 1995). The restriction of HGF ligand and receptor to heart precursor cells occurs between days E7.5 and E8.0. At a parallel time in the chick, HGF induces neuroectoderm and may also be a chemoattractant for mesoderm. 34 35 In the mouse, HGF induces rapid migration of primitive streak cells isolated from the midgastrulation embryo (C.A. Burdsal and D.A. Rappolee, unpublished data, 1995) . One possibility is that HGF produced in the midgastrulation primitive streak may participate in the induction of heart mesoderm as well as inducing neuroectoderm.
Lack of gross defects in heart development of HGF null mutants may be due to functional redundancy of HGF and related ligands during early heart development. Ron and Sea are related to the HGF cmet/receptor. 32 33 47 These have homology in the extracellular domain, but HGF/SF and HGF-like protein/MSP have no cross-reactivity through these receptors. 32 33 41 The expression of the HGF-related ligand and HGF-like protein/MSP have not been determined at this stage of development. However, HGF and MSP probably do not compete for the HGF c-met/receptor or Ron or Sea, 23 24 suggesting that known ligands and receptors of the family would not be redundant or compensatory. But as-yetundiscovered ligands may bind the HGF receptor expressed in the early cardiac myocytes in the absence of HGF. Ligands not related to HGF may also be functionally redundant during heart development. TGF-ß2 ligand and FGF-8 are also expressed in pharyngeal endoderm and early myocardial mesoderm at day E7.75, at a time when these are candidates for mediating endodermal induction of heart mesoderm or migration. 15 16 These unrelated growth factors may have overlapping function with HGF.
We have presented evidence for transient expression, and largely coexpression, of mRNA transcripts for HGF ligand and receptor in early cardiac myocytes. Expression occurs in a period of time after the heart is determined and before the heart begins to beat or to loop. It is likely that HGF plays a role in the migration of early myocardial cells before formation of the heart tube or in coordinating the program of differentiation or growth of myocardial cells. It is unlikely that HGF plays a role in the early induction of heart by endoderm or in the determination of heart cells. Although null mutants for HGF do not have gross heart deformation as a phenotype, signaling by HGF family members may play an important role in the early development of the heart. 
Selected Abbreviations and Acronyms
